Certificate number:RU.77.99.11.003.E.000453.02.17
Date of registration and renewal:01.02.2017
Dosage form: & nbspTablets weighing 1218 mg.
Classification "Composition" & nbsp BAD - products of plant, animal or mineral origin BAD - vitamin and mineral complexes
Classification "Clinical" & nbsp BAD-sources of vitamin-mineral complexes Supplements containing zinc, copper, manganese Supplements containing calcium and phosphorus Supplements containing iron Supplements containing iodine Supplements containing potassium and magnesium
Composition: & nbspCalcium phosphate, E460, magnesium oxide, ascorbic acid, calcium carbonate, iron fumarate, palm oil, E466, beta carotene, nicotinamide, zinc sulfate, E570, E464, calcium pantothenate, E470b, pyridoxine hydrochloride, riboflavin-5-phosphate tensioned dence , thiamine mononitrate, E171, cyanocobalamin, cholecalciferol, folic acid, E551, E1201, biotin, E553b, E463, hydrogenated vegetable oil, E172, potassium iodate.
Scope: & nbspTo implement the public as a biologically active food supplement additional source of vitamins A, D3, C, B1, B2, B6, B12, folic acid, biotin, niacin, pantothenic acid and minerals (calcium, magnesium, iron, zinc, iodine) .
Suggested Usage: & nbspWomen 1 tablet 1 time per day. Duration of admission is 3 months. After a break of 1 month, a second appointment is possible.
Contraindications:Individual intolerance of components.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:3 years.
Storage conditions:Store in a dry place inaccessible to children, at a temperature not exceeding + 25 ° С.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.11.003.Е.010093.11.15 of 12.11.2015, the expert opinion of the Federal State Research Institution of Nutrition No. 72 / Э-1205 / б-15 of August 27, 2015.
Recipient:Kvayser Pharma, Open CompanyKvayser Pharma, Open Company Russian Federation
Information update date: & nbsp20.02.2017
Instructions
Up